Skip to content

Odyssey Study

Evaluation of the Visual and Functional Performance of a Full Range of Field Intraocular Lens in Patients with Cataract - Odyssey Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON58173
Enrollment
30
Registered
2025-08-12
Start date
2026-01-15
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cataract

Interventions

TECNIS Odyssey intraocular lens. No medical interventions are performed as part of the study.

Sponsors

Amphia Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Age =18 yearsBilateral implantation of the TECNIS Odyssey IOLPostoperative manifest spherical euqivalent error between +0.5 D and -0.75 D in both eyesPostoperative manifest astigmatism =0.75 D in both eyesCDVA =0.1 logMAR in both eyesProficiency in Dutch language to be able to complete PROMs independentlyNormal ability to read

Exclusion criteria

Exclusion criteria: Ocular comorbidity that may significantly affect vision (e.g., macula degeneration, diabetic retinopathy, glaucoma)Systemic conditions that may significantly affect visual function (e.g., history of stroke)Presence of posterior capsule opacification on slit-lamp examinationIntraoperative or postoperative complications significantly affecting vision and have not resolved 3 months after surgerySecond-eye surgery not performed within 3 months of the first-eye surgery

Design outcomes

Primary

MeasureTime frame
Best-corrected distance visual acuity (CDVA) per eye at 4 meters.

Secondary

MeasureTime frame
In this study we also look at several other aspects of vision. These include how well patients can see at reading and computer distance, how large their pupils are in bright and dim light, and how well they can distinguish light from dark under different lighting conditions (contrast vision). We assess reading ability by measuring reading speed and clarity. We also look at the remaining prescription of the eye, such as any small amount of far- or nearsightedness or astigmatism. In addition, patients complete short questionnaires about their vision in daily life, including their need for glasses and any light-related symptoms. Finally, we check the eyes for any findings that may influence vision, such as early signs of posterior capsule opacification.

Countries

Netherlands

Contacts

Public ContactN.J. Reus

Amphia Ziekenhuis

oogresearch@amphia.nl0765952293

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Mar 20, 2026